Acurx Pharmaceuticals Statistics Share Statistics Acurx Pharmaceuticals has 1.54M
shares outstanding. The number of shares has increased by 0.03%
in one year.
Shares Outstanding 1.54M Shares Change (YoY) 0.03% Shares Change (QoQ) 1.64% Owned by Institutions (%) 7.25% Shares Floating 1.34M Failed to Deliver (FTD) Shares 680 FTD / Avg. Volume 0.21%
Short Selling Information The latest short interest is 638.16K, so 2.15% of the outstanding
shares have been sold short.
Short Interest 638.16K Short % of Shares Out 2.15% Short % of Float 2.37% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.02 and the forward
PE ratio is -0.44.
Acurx Pharmaceuticals's PEG ratio is
0.
PE Ratio -0.02 Forward PE -0.44 PS Ratio 0 Forward PS 24.9 PB Ratio 427.78 P/FCF Ratio -25.34 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Acurx Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.19,
with a Debt / Equity ratio of 0.
Current Ratio 1.19 Quick Ratio 1.19 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.53B Employee Count 4 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -88.07% in the
last 52 weeks. The beta is -1.26, so Acurx Pharmaceuticals's
price volatility has been lower than the market average.
Beta -1.26 52-Week Price Change -88.07% 50-Day Moving Average 8.46 200-Day Moving Average 14.41 Relative Strength Index (RSI) 26.64 Average Volume (20 Days) 325,041
Income Statement
Revenue n/a Gross Profit n/a Operating Income -14.1M Net Income -14.1B EBITDA -14.1M EBIT -14.1M Earnings Per Share (EPS) -17450.8
Full Income Statement Balance Sheet The company has 3.71M in cash and 0 in
debt, giving a net cash position of 3.71M.
Cash & Cash Equivalents 3.71M Total Debt n/a Net Cash n/a Retained Earnings -67.32M Total Assets 4.8M Working Capital -2.49B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -10.38M
and capital expenditures 0, giving a free cash flow of -10.38M.
Operating Cash Flow -10.38M Capital Expenditures n/a Free Cash Flow -10.38M FCF Per Share -0.64
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ACXP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ACXP is $160,
which is 3487.4% higher than the current price. The consensus rating is "Buy".
Price Target $160 Price Target Difference 3487.4% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 5, 2025. It was a
backward
split with a ratio of 1:20.
Last Split Date Aug 5, 2025 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -652.96 Piotroski F-Score 1
